Laurion Capital Management LP Pyxis Oncology, Inc. Transaction History
Laurion Capital Management LP
- $7.27 Billion
- Q3 2024
A detailed history of Laurion Capital Management LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 3,625,974 shares of PYXS stock, worth $6.09 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,625,974
Previous 3,861,179
6.09%
Holding current value
$6.09 Million
Previous $12.8 Million
4.12%
% of portfolio
0.18%
Previous 0.15%
Shares
5 transactions
Others Institutions Holding PYXS
# of Institutions
101Shares Held
28.2MCall Options Held
539KPut Options Held
54.1K-
Deep Track Capital, LP Greenwich, CT4.18MShares$7.03 Million0.57% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$4.68 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$4.09 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.91MShares$3.2 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.13MShares$1.89 Million1.36% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $59M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...